CL2008000394A1 - Compuestos derivados de azabicicloalcano; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos asociados a la enfermedad de alzheimer, parkinson, patologias psiquiatricas, accidentes vasculares cerebrales, sindr - Google Patents

Compuestos derivados de azabicicloalcano; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos asociados a la enfermedad de alzheimer, parkinson, patologias psiquiatricas, accidentes vasculares cerebrales, sindr

Info

Publication number: CL2008000394A1
Authority: CL; Chile
Prior art keywords: compounds; sindr; azabicicloalcano; parkinson; alzheimer
Prior art date: 2007-02-09

Application number

CL200800394A

Other languages

English (en)

Inventor

Ayad Omar Leclerc Odile Lo Ben

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-09

Filing date

2008-02-07

Publication date

2008-06-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000394(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-07 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2008-06-13 Publication of CL2008000394A1 publication Critical patent/CL2008000394A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Psychology (AREA)
Hematology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

CL200800394A 2007-02-09 2008-02-07 Compuestos derivados de azabicicloalcano; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos asociados a la enfermedad de alzheimer, parkinson, patologias psiquiatricas, accidentes vasculares cerebrales, sindr CL2008000394A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0700940A FR2912404B1 (fr)	2007-02-09	2007-02-09	Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.

Publications (1)

Publication Number	Publication Date
CL2008000394A1 true CL2008000394A1 (es)	2008-06-13

Family

ID=38523491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200800394A CL2008000394A1 (es)	2007-02-09	2008-02-07	Compuestos derivados de azabicicloalcano; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos asociados a la enfermedad de alzheimer, parkinson, patologias psiquiatricas, accidentes vasculares cerebrales, sindr

Country Status (39)

Country	Link
US (2)	US8173669B2 (es)
EP (1)	EP2118104B1 (es)
JP (1)	JP5356257B2 (es)
KR (1)	KR101517629B1 (es)
CN (1)	CN101605793B (es)
AR (1)	AR065248A1 (es)
AU (1)	AU2008224785B2 (es)
BR (1)	BRPI0806969A2 (es)
CA (1)	CA2677713C (es)
CL (1)	CL2008000394A1 (es)
CO (1)	CO6220857A2 (es)
CR (1)	CR10969A (es)
CY (1)	CY1113896T1 (es)
DK (1)	DK2118104T3 (es)
DO (1)	DOP2009000186A (es)
EA (1)	EA017802B1 (es)
EC (1)	ECSP099568A (es)
ES (1)	ES2402328T3 (es)
FR (1)	FR2912404B1 (es)
GT (1)	GT200900206A (es)
HN (1)	HN2009001484A (es)
HR (1)	HRP20130279T1 (es)
IL (1)	IL199966A (es)
MA (1)	MA31233B1 (es)
MX (1)	MX2009008492A (es)
MY (1)	MY161067A (es)
NI (1)	NI200900157A (es)
NZ (1)	NZ578673A (es)
PE (1)	PE20081664A1 (es)
PL (1)	PL2118104T3 (es)
PT (1)	PT2118104E (es)
SI (1)	SI2118104T1 (es)
SV (1)	SV2009003347A (es)
TN (1)	TN2009000314A1 (es)
TW (1)	TWI395585B (es)
UA (1)	UA97833C2 (es)
UY (1)	UY30908A1 (es)
WO (1)	WO2008110699A2 (es)
ZA (1)	ZA200905511B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR063142A1 (es) *	2006-10-04	2008-12-30	Pharmacopeia Inc	Derivados de 2-(bencimidazolil) purina y purinonas 6-sustituidas utiles como inmunosupresores,y composiciones farmaceuticas que los contienen.
RU2537390C1 (ru) *	2013-07-02	2015-01-10	Федеральное государственное унитарное предприятие "Государственный завод медицинских препаратов"	Способ получения 2-экзо-[3'-(6'-хлорпиридил)]-7-азабицикло[2.2.1]-гептана
WO2016015333A1 (en) *	2014-08-01	2016-02-04	F.Hoffmann-La Roche Ag	2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives
CN111777593B (zh) *	2019-04-03	2024-07-23	南京天印健华医药科技有限公司	作为转染期间重排激酶抑制剂的新的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8610130D0 (en) *	1986-04-25	1986-05-29	Wellcome Found	Pesticidal compounds
WO1995003306A1 (en) *	1993-07-22	1995-02-02	E.I. Du Pont De Nemours And Company	Arthropodicidal azacyclic heterocycles
FR2834511B1 (fr) *	2002-01-07	2004-02-13	Sanofi Synthelabo	Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
AU2004247319A1 (en)	2003-06-12	2004-12-23	Novo Nordisk A/S	Pyridinyl carbamates as hormone-sensitive lipase inhibitors
FR2889701B1 (fr) *	2005-08-12	2007-10-05	Sanofi Aventis Sa	Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.

2007
- 2007-02-09 FR FR0700940A patent/FR2912404B1/fr not_active Expired - Fee Related
2008
- 2008-01-24 TW TW097102652A patent/TWI395585B/zh not_active IP Right Cessation
- 2008-02-04 CN CN2008800045359A patent/CN101605793B/zh not_active Expired - Fee Related
- 2008-02-04 JP JP2009548712A patent/JP5356257B2/ja not_active Expired - Fee Related
- 2008-02-04 MY MYPI20093204A patent/MY161067A/en unknown
- 2008-02-04 PT PT87618401T patent/PT2118104E/pt unknown
- 2008-02-04 PL PL08761840T patent/PL2118104T3/pl unknown
- 2008-02-04 WO PCT/FR2008/000137 patent/WO2008110699A2/fr not_active Ceased
- 2008-02-04 SI SI200830925T patent/SI2118104T1/sl unknown
- 2008-02-04 EP EP08761840A patent/EP2118104B1/fr active Active
- 2008-02-04 EA EA200970745A patent/EA017802B1/ru not_active IP Right Cessation
- 2008-02-04 DK DK08761840.1T patent/DK2118104T3/da active
- 2008-02-04 KR KR1020097016530A patent/KR101517629B1/ko not_active Expired - Fee Related
- 2008-02-04 BR BRPI0806969-7A2A patent/BRPI0806969A2/pt not_active IP Right Cessation
- 2008-02-04 ES ES08761840T patent/ES2402328T3/es active Active
- 2008-02-04 MX MX2009008492A patent/MX2009008492A/es active IP Right Grant
- 2008-02-04 NZ NZ578673A patent/NZ578673A/en not_active IP Right Cessation
- 2008-02-04 ZA ZA200905511A patent/ZA200905511B/xx unknown
- 2008-02-04 HR HRP20130279AT patent/HRP20130279T1/hr unknown
- 2008-02-04 CA CA2677713A patent/CA2677713C/fr not_active Expired - Fee Related
- 2008-02-04 AU AU2008224785A patent/AU2008224785B2/en not_active Ceased
- 2008-02-07 AR ARP080100527A patent/AR065248A1/es unknown
- 2008-02-07 PE PE2008000275A patent/PE20081664A1/es not_active Application Discontinuation
- 2008-02-07 CL CL200800394A patent/CL2008000394A1/es unknown
- 2008-02-08 UY UY30908A patent/UY30908A1/es not_active Application Discontinuation
- 2008-04-02 UA UAA200909264A patent/UA97833C2/ru unknown
2009
- 2009-07-20 IL IL199966A patent/IL199966A/en not_active IP Right Cessation
- 2009-07-21 GT GT200900206A patent/GT200900206A/es unknown
- 2009-07-22 DO DO2009000186A patent/DOP2009000186A/es unknown
- 2009-07-30 TN TNP2009000314A patent/TN2009000314A1/fr unknown
- 2009-07-31 SV SV2009003347A patent/SV2009003347A/es unknown
- 2009-08-04 US US12/535,156 patent/US8173669B2/en not_active Expired - Fee Related
- 2009-08-05 CO CO09081875A patent/CO6220857A2/es active IP Right Grant
- 2009-08-06 CR CR10969A patent/CR10969A/es unknown
- 2009-08-07 EC EC2009009568A patent/ECSP099568A/es unknown
- 2009-08-07 NI NI200900157A patent/NI200900157A/es unknown
- 2009-08-07 HN HN2009001484A patent/HN2009001484A/es unknown
- 2009-09-01 MA MA32196A patent/MA31233B1/fr unknown
2012
- 2012-03-16 US US13/422,296 patent/US8759343B2/en not_active Expired - Fee Related
2013
- 2013-04-02 CY CY20131100273T patent/CY1113896T1/el unknown

Also Published As

Publication number	Publication date
PL2118104T3 (pl)	2013-05-31
ZA200905511B (en)	2010-10-27
US8173669B2 (en)	2012-05-08
PT2118104E (pt)	2013-03-25
MA31233B1 (fr)	2010-03-01
WO2008110699A2 (fr)	2008-09-18
EP2118104A2 (fr)	2009-11-18
US20100035916A1 (en)	2010-02-11
KR101517629B1 (ko)	2015-05-04
JP2010518053A (ja)	2010-05-27
KR20090106600A (ko)	2009-10-09
US20120202807A1 (en)	2012-08-09
BRPI0806969A2 (pt)	2014-04-08
AU2008224785A1 (en)	2008-09-18
CN101605793B (zh)	2013-04-24
US8759343B2 (en)	2014-06-24
IL199966A0 (en)	2010-04-15
WO2008110699A3 (fr)	2009-01-15
EA200970745A1 (ru)	2010-02-26
TN2009000314A1 (fr)	2010-12-31
HK1139671A1 (en)	2010-09-24
FR2912404B1 (fr)	2009-04-10
CA2677713A1 (fr)	2008-09-18
DK2118104T3 (da)	2013-04-08
CO6220857A2 (es)	2010-11-19
TWI395585B (zh)	2013-05-11
ES2402328T3 (es)	2013-04-30
MY161067A (en)	2017-04-14
PE20081664A1 (es)	2008-12-14
CN101605793A (zh)	2009-12-16
HN2009001484A (es)	2012-01-16
UY30908A1 (es)	2008-09-30
TW200838519A (en)	2008-10-01
AR065248A1 (es)	2009-05-27
NZ578673A (en)	2011-12-22
HRP20130279T1 (hr)	2013-04-30
NI200900157A (es)	2010-07-15
MX2009008492A (es)	2009-09-28
FR2912404A1 (fr)	2008-08-15
IL199966A (en)	2014-11-30
JP5356257B2 (ja)	2013-12-04
CR10969A (es)	2009-10-23
DOP2009000186A (es)	2009-09-15
EA017802B1 (ru)	2013-03-29
SV2009003347A (es)	2010-02-01
GT200900206A (es)	2011-08-18
CA2677713C (fr)	2015-11-24
AU2008224785B2 (en)	2013-03-14
ECSP099568A (es)	2009-09-29
EP2118104B1 (fr)	2013-01-02
CY1113896T1 (el)	2016-07-27
UA97833C2 (ru)	2012-03-26
SI2118104T1 (sl)	2013-05-31

Similar Documents

Publication	Publication Date	Title
BRPI0818799A2 (pt)	2015-04-22	Composições para o tratamento da doença de parkinson
CL2008000703A1 (es)	2008-09-26	Compuestos derivados de pirimidinas sustituidas; procedimiento para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar transtornos hematologicos.
CL2007002641A1 (es)	2008-06-20	Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
CL2013001295A1 (es)	2013-10-04	Compuestos derivados de 2,3-dihidromidazo (1,2-c) quinazolina sustituidos con aminoalcoholes; compuesto intermediario y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis.
CO6781485A2 (es)	2013-10-31	Compuestos y su uso como inhibidores de bace
CL2007001882A1 (es)	2008-02-08	Compuestos derivados de imidazopirimidina; proceso para preparar los compuestos; composicion farmaceutica; y uso para la prevencion y/o tratamiento de desordenes cognitivos.
CL2008000330A1 (es)	2008-08-08	Compuestos derivados de octahidro fenantreno sustituidos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar asma, dermatitis, enfermedad de alzheimer, artritis, entre otras enfermedades.
BRPI0822111A2 (pt)	2015-06-16	Uso de uma composição líquida na fabricação de uma composição para prevenir e/ou tratar declínio da memória e/ou da disfunção cognitiva, mal de alzheimer, mal de parkinson e/ou demência, composição líquida, e, composição nutricional
CL2008000369A1 (es)	2008-04-18	Compuestos derivados de piridopirimidinonas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dolor, depresion, enfermedades cardiovasculares, enfermedades respiratorias y enfermedades psiquiatricas.
CL2007001881A1 (es)	2008-02-08	Compuestos derivados de imidazopirimidina; proceso para preparar los compuestos; composicion farmaceutica; y uso para la prevencion y/o tratamiento de desordenes cognitivos.
CL2008000531A1 (es)	2008-09-22	Compuestos derivados de heterociclos, inhibidores de la aspartilproteasa; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades cardiovasculares, cognitivas y neurodegenerativas tales como la enfermeda
IL213259A0 (en)	2011-07-31	Composition for the use to treat alzheimer's disease
GT201200250A (es)	2014-11-13	Ariltriazolonas ligadas a bisarilo y su uso
BRPI0912362A2 (pt)	2015-10-06	antagonista do receptor nmda para o tratamento de transtornos neuropsiquiátricos
CL2013001604A1 (es)	2014-07-25	Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis.
CL2008000224A1 (es)	2008-05-23	Composicion farmaceutica que comprende un compuesto derivado glucopiranosilo; y uso para el tratamiento de uno o mas trastornos neurodegenerativos.
CL2008000738A1 (es)	2008-09-22	Compuestos derivados de malonamida; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la depresion, enfermedad de parkinson y alzheimer, entre otras enfermeda
DK2303330T4 (da)	2021-09-13	Farmaceutiske sammensætninger til behandling af parkinsons sygdom
PA8770101A1 (es)	2009-05-15	Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
BRPI0918527A2 (pt)	2015-12-01	compostos para o tratamento de disturbios do cns
ES2764480T8 (es)	2020-07-24	Composiciones de combinación para tratar la enfermedad de Alzheimer y trastornos relacionados con zonisamida y acamprosato
CL2008000754A1 (es)	2008-10-24	Compuesto derivado de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar cancer y trastornos hiperproliferativos.
CL2007001731A1 (es)	2008-01-25	Compuestos derivados de imidazo[1,5-a]pirimidina; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras.
CL2007001732A1 (es)	2008-01-25	Compuestos derivados de imidazo[1,5-a]pirimidina; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras.
BRPI1009252A2 (pt)	2016-03-15	composto, pró-droga, composição farmacêutica, métodos para prevenir ou tratar doenças do sistema nervoso central, e mal de alzheimer, e, uso do composto ou de uma pró-droga do mesmo